Endocan: a new marker of endothelial function

Sevket Balta; Ilknur Balta; Dimitri P Mikhailidis

doi:10.1097/HCO.0000000000000867

Endocan: a new marker of endothelial function

Curr Opin Cardiol. 2021 Jul 1;36(4):462-468. doi: 10.1097/HCO.0000000000000867.

Authors

Sevket Balta¹, Ilknur Balta², Dimitri P Mikhailidis^{3

4}

Affiliations

¹ Department of Cardiology, Hayat Hospital, Malatya.
² Department of Dermatology, Ankara Training and Research Hospital, Ankara, Turkey.
³ Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School London, University College London (UCL), London, UK.
⁴ Mohammed Bin Rashid University (MBRU) of Medicine and Health Sciences, Dubai.

PMID: 33929364
DOI: 10.1097/HCO.0000000000000867

Abstract

Purpose of review: To consider the role of endocan as an inflammatory marker in cardiovascular diseases.

Recent findings: Endocan, an endothelial inflammatory marker, is associated with cardiovascular disease.

Summary: Vascular endothelial inflammation plays a key role in the pathogenesis of inflammatory and cardiovascular diseases by influencing thrombogenesis, tumour invasion and secretion of bioactive mediators. We discuss the role of endocan mainly in the context of cardiology.

Publication types

Review

MeSH terms

Biomarkers
Cardiovascular Diseases* / diagnosis
Endothelium, Vascular
Humans
Neoplasm Proteins
Proteoglycans*

Substances

Biomarkers
Neoplasm Proteins
Proteoglycans